Navigation Links
Ovarian cancer screening saves few lives

The best currently available screening tests can only slightly reduce ovarian cancer deaths. That is the conclusion of new research published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results suggest that strategies other than screening, such as prevention and better treatments, will be needed to significantly lower the number of women who die from ovarian cancer.

No screening program for ovarian cancer has been proven to save lives, mainly because the disease is uncommon and tends to grow and spread without causing symptoms. Laura Havrilesky, MD, MHSc, of the Duke University Medical Center in Durham, led a team that recently designed a computer-based model of the progression of ovarian cancer from early to late stages. The model, which takes into account the fact that certain ovarian cancers are slow growing while others grow more quickly, can test the effectiveness of screening strategies for reducing the number of deaths from ovarian cancer.

The researchers discovered that annual screening for ovarian cancer is likely to result in only a modest reduction in mortality from the disease. "If we assume ovarian cancers grow and spread at different rates, the best screening strategy available will only reduce the number of women dying from this cancer by 11 percent. This is partially because the slower growing cancers are more likely to be caught by a screening test," said Dr. Havrilesky. The findings support the commonly held clinical impression that many early stage ovarian cancers are destined to remain in the early stages for some time, while advanced stage cancers have likely spread rapidly.

More sensitive screening tests will be needed to significantly reduce deaths attributed to ovarian cancer. For now, other measures that focus on prevention and treatment should be pursued to save women's lives.

In an accompanying editorial, Patricia Hartge, MA, ScD, of the National Cancer Institute in Rockville noted that for women who are at a higher risk for developing ovarian cancerfor example because of the presence of known cancer-causing gene mutations or a significant family history of ovarian cancerscreening presents a more hopeful picture. In this regard, targeted screening could help reduce deaths attributed to ovarian cancer. She added that the results from ongoing randomized clinical trials will provide the strongest evidence about the potential for reducing ovarian cancer deaths through screening.


Contact: Jennifer Beal

Related biology news :

1. Genetic testing for breast or ovarian cancer risk may be greatly underutilized
2. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
3. Ovarian transplantation: First baby is born after a new technique
4. Genetic factors implicated in survival gap for breast, ovarian or prostate cancer
5. 2 reproductive factors are important predictors of death from ovarian cancer
6. Nanoparticle-delivered suicide genes slowed ovarian tumor growth
7. Disarming specialized stem cells might combat deadly ovarian cancer
8. FDA approved leukemia drugs shows promise in ovarian cancer cells
9. Assessing lead time of selected ovarian cancer biomarkers
10. Dietary factors influence ovarian cancer survival rates
11. The pill for ovarian cysts
Post Your Comments:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions to ... symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory science, ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
(Date:10/7/2017)... Oct. 6, 2017  The 2017 Nobel Prize ... scientists, Jacques Dubochet, Joachim Frank and ... cryo-electron microscopy (cryo-EM) have helped to ... structural biology community. The winners worked with systems ... routinely produce highly resolved, three-dimensional images of protein ...
Breaking Biology Technology: